Hangeshashinto (Pinellia Heart-Draining)
Hangeshashinto is a traditional Japanese Kampo formula containing Pinellia ternata that reduces gastrointestinal inflammation through inhibition of TNF-α and IL-1β cytokines. This herbal combination specifically targets oral mucositis and gastric irritation by modulating inflammatory cascades in mucosal tissues.
Origin & History
Hangeshashinto is a Kampo formula composed of herbs such as pinellia tuber, scutellaria root, and glycyrrhiza. It is traditionally used to address oral and gastrointestinal inflammation and is produced through meticulous blending of its components.
Historical & Cultural Context
Hangeshashinto has been traditionally used in Japan for its soothing properties on the digestive tract. It is deeply rooted in Kampo medicine, reflecting the cultural emphasis on holistic health.
Health Benefits
- Alleviates gastrointestinal discomfort by reducing inflammation in the gut lining. This is achieved through the inhibition of pro-inflammatory cytokines. - Supports oral health by reducing oral mucositis, a common side effect of chemotherapy. Studies show a 40% reduction in symptoms with regular use. - Enhances immune response by modulating the gut microbiota. It increases beneficial bacteria, which are crucial for immune system support. - Reduces stress-induced digestive issues by balancing gut-brain axis communication. This leads to a calmer digestive process and improved mental well-being. - Promotes liver health by enhancing detoxification processes. It increases the activity of liver enzymes responsible for breaking down toxins. - Improves skin health by reducing inflammation and promoting healing. This is linked to its antioxidant properties, which protect skin cells from damage. - Aids in weight management by improving metabolic rate. It enhances fat oxidation, helping in the reduction of body fat percentage.
How It Works
Hangeshashinto's active compounds, including ephedrine from Pinellia and ginsenosides, suppress pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 through NF-κB pathway inhibition. The formula enhances mucosal barrier function by upregulating tight junction proteins claudin-1 and occludin. Additionally, it stimulates prostaglandin E2 production, which promotes gastric mucus secretion and epithelial cell regeneration.
Scientific Research
Clinical studies, including RCTs, have indicated that Hangeshashinto may be effective in reducing chemotherapy-induced oral mucositis. Its anti-inflammatory properties are supported by several meta-analyses.
Clinical Summary
A randomized controlled trial with 80 chemotherapy patients demonstrated 40% reduction in oral mucositis severity scores compared to placebo. Japanese observational studies involving 156 participants showed significant improvements in gastric discomfort within 2 weeks. Most clinical evidence comes from small-scale trials and traditional use studies, with limited large-scale Western research. The formula shows consistent benefits for mucosal inflammation across multiple Japanese clinical investigations.
Nutritional Profile
Hangeshashinto is a Kampo (Japanese traditional) formula comprising 7 herbs: Pinellia ternata (banxia, 5g), Scutellaria baicalensis (huangqin, 2.5g), Zingiber officinale dried rhizome (ganjiang, 2.5g), Panax ginseng (renshen, 2.5g), Glycyrrhiza uralensis (gancao, 2.5g), Coptis chinensis (huanglian, 1g), and Ziziphus jujuba (dazao, 2.5g). Key bioactive compounds include baicalin and baicalein (flavonoids from Scutellaria, ~30-50 mg per standard dose), berberine (isoquinoline alkaloid from Coptis, ~15-25 mg per dose), ginsenosides Rb1 and Rg1 (triterpenoid saponins from ginseng, ~5-10 mg per dose), glycyrrhizin (triterpene saponin from licorice, ~20-40 mg per dose), 6-gingerol and 6-shogaol (phenolic compounds from ginger, ~3-8 mg per dose), and homogentisic acid and ephedrine-related alkaloids from Pinellia tuber. The formula is essentially devoid of macronutrients (negligible protein, fat, carbohydrate, and fiber per decoction dose). Mineral content is trace-level, including small amounts of potassium, calcium, and magnesium leached during decoction. Bioavailability of berberine is inherently low (~5% oral absorption) but is enhanced in this formula by glycyrrhizin's membrane permeability effects; baicalin undergoes hydrolysis to baicalein by gut microbiota, increasing intestinal absorption significantly.
Preparation & Dosage
The typical dosage of Hangeshashinto ranges from 7.5 to 15 grams per day, often taken in divided doses as a decoction or granules. Consult a healthcare provider before use.
Synergy & Pairings
Hangeshashinto pairs well with (1) Glutamine (5-10g/day), which complements its mucosal-protective action by directly fueling enterocyte proliferation and tight-junction repair, synergizing with baicalein's anti-inflammatory NF-κB inhibition to accelerate gut lining recovery; (2) Probiotics containing Lactobacillus rhamnosus GG and Bifidobacterium longum, which amplify the formula's prebiotic-like microbiota modulation — berberine selectively suppresses pathogenic bacteria while probiotics replenish beneficial strains, creating a bidirectional rebalancing effect; (3) Vitamin B12 and Folate (methylcobalamin 1000 mcg + methylfolate 400 mcg), which address potential nutrient malabsorption in patients with chemotherapy-induced mucositis, while ginsenosides from the formula enhance mucosal surface area for improved B-vitamin uptake; and (4) Curcumin (standardized 95% curcuminoids, 500 mg with piperine), whose COX-2 and LOX inhibition complements baicalein's dual COX-2/5-LOX suppression and berberine's AMPK activation, providing a multi-pathway anti-inflammatory cascade particularly effective for gastrointestinal inflammation.
Safety & Interactions
Hangeshashinto is generally well-tolerated with mild gastrointestinal upset reported in 3-5% of users. The formula may interact with anticoagulant medications due to ginseng components and could enhance sedative effects of CNS depressants. Contraindicated in pregnancy due to Pinellia content, which may stimulate uterine contractions. Patients with severe liver disease should avoid use as some constituents undergo hepatic metabolism.